HI-Bio: A Biogen Company Alternatives & Competitors
12 companies similar to HI-Bio: A Biogen Company — HI-Bio is a clinical-stage biotech company delivering targeted therapies for pat...
Companies similar to HI-Bio: A Biogen Company
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
San Diego, United States
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Rival Readout
Competing with HI-Bio: A Biogen Company? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Shanghai, China
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Calithera Biosciences
Targeting cancer, differently.
South San Francisco, Unit...
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Cambridge, United States
About HI-Bio: A Biogen Company
HI-Bio, a clinical-stage biotech company, has made a notable impact in the realm of biotechnology since its founding in 2021. The company's focus on delivering targeted therapies for patients with immune-mediated diseases aligns with its mission to innovate in the Biotechnology, Health and Wellness, and Life Sciences i...
Research and Development, Clinical Trials, Medicine Manufacturing, Early Access Programs, Healthcare Innovation
Medical Professionals, Patients, Researchers, Investors
Immune-mediated Diseases, Targeted Therapies, Clinical-stage, Felzartamab, Anti-CD38 Monoclonal Antibody, Immune Cell Depletion, Plasma Cells, Natural Killer Cells, Immunology, Therapeutics Development, Clinical Outcomes, Biopharmaceuticals, Antibody Therapies
B2B, B2D, B2B2C
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around HI-Bio: A Biogen Company: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at HI-Bio: A Biogen Company on 28 Jan 2026. The 12 companies listed here were last checked between 27 Oct 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
